Claire Harrison
@harrisoncn1
Mum, clinician, haematologist, educator. Views my own.
ID:3863426362
http://www.mpnvoice.org.uk 04-10-2015 16:49:25
1,1K Tweets
1,4K Followers
948 Following
Follow People
Primary or secondary myelofibrosis, does it make a difference?
See our experience Hôpital Saint-Louis AP-HP AP-HP Université Paris Cité AmericanJournalofHematology #MPNsm #CentreIntégréDesNMP
👉 doi.org/10.1002/ajh.27…
📣 #ESHMPN2024 ONLY 3 WEEKS LEFT TO SUBMIT YOUR ABSTRACT!
Proceed now ➡️ bit.ly/3PALAGS
10th Translational Research Conference MYELOPROLIFERATIVE NEOPLASMS
🗓️ April 26-28, 2024 in Mandelieu 🇫🇷
Chairs: J.J. Kiladjian, Ross Levine, Jyoti Nangalia
#ESHCONFERENCES #MPNsm
👉👉👉Please Join us now for #MPNSM Nasyiah Uswatun K seminar and discussion now on live !
J.J. Kiladjian Tania Jain Claire Harrison Naveen Pemmaraju, MD Ruben A. Mesa, MD Mohamad Mohty
bit.ly/48mPRV4
@ASH2023@MPNSM great poster from Patrick Harrington, Andrea Dumenico and the AI / cogstack team from@GSTTnhs highlighting the use of AI and the importance of QRisk 3 in CV risk Patrick Harrington congrats team
Naveen Pemmaraju, MD and Raajit Rampal, M.D.Ph.D. threw down the MPN gauntlet at #ASH23 ! Which is the better front line myelofibrosis combination therapy? Aaron Gerds MD, MS Claire Harrison J.J. Kiladjian Prithviraj Bose Stephen Oh Lucia Masarova, MD Brandi Reeves Lindsay Rein Levine Cancer Wake Forest Baptist - Comprehensive Cancer Center
…here is the important point ….a single point change in PGIC correlated with a 1.67 point change in median TSS…. So look at these differences in ph3 data & wider benefits eg anaemia & side effects @MPDRC @MPNSM Naveen Pemmaraju, MD Raajit Rampal, M.D.Ph.D.
& ensure you can give a good rux dose
Novel “Time Without Transfusion” metric for quantifying the cumulative benefit of anemia in myelofibrosis patients treated with momelotinib: #ASH23 #mpnsm GSK Wake Forest Baptist - Comprehensive Cancer Center Levine Cancer #LevineCancer Atrium Health Atrium HealthWFB
An amazing rare MPN/ mast cell focused session kicking off with the fascinating concept of fedratinib for CNL aCML from Andrew Kuykendall MD @mpnsm
@MPNSM MPN Voice Guy's and St Thomas' Guy's and St Thomas' Research Truly inspirational view from our CRF today am up here working with our team delivering innovative first of a kind therapies for our patients! Well done team!